Interestingly, adiponectin inhibits the growth of cultured colorectal cancer cells in vitro via activation of adenosine monophosphate-activated protein kinase (AMPK) and suppresses the mammalian target of rapamycin (mTOR) pathway [20,21]. The gene discussed is MTOR; the disease is colorectal cancer.